Ocugen is trading 8.33% down at MXN 22.00, with no clear company-specific catalyst reported for September 9, 2026.
- Ocugen is scheduled to present at the Citi 2026 Biopharma Back to School Conference later on September 9.
- Available coverage does not link the event to the decline.
- Broader markets are only modestly lower, offering limited support for a global-market explanation.